Nasdaq IPOs

C4 Therapeutics, a preclinical biotech developing small molecule protein degraders to treat cancer, announced terms for its IPO on Monday. The Watertown, MA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to $18. At the midpoint of

Oncorus, a Phase 1 biotech developing oncolytic virus therapies for solid tumors, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $87 million by offering 5.8 million shares at a price range of $14 to $16. At the midpoint of the proposed range

Updated Monday, 9/28. 11 IPOs and two direct listings are scheduled to go public in the week ahead. The diverse group includes three foreign tech issuers, two biotechs, two US tech unicorns, a sporting goods retailer, an avocado supplier, a medical device maker, and a foreign edu

Nine IPOs and two direct listings are scheduled to go public in the week ahead. The diverse group includes three foreign tech issuers, two biotechs, two US tech unicorns, a sporting goods retailer, an avocado supplier, a medical device maker, and a foreign education company. More

September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx (GDRX) priced well above the range to rais

Tarsus Pharmaceuticals, a late stage biopharmaceutical company focused on the development of therapeutics for ophthalmic conditions, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The company's lead product candidate, TP-03, is a novel ther

Praxis Precision Medicines, a Phase 2 biotech developing therapies for CNS disorders using genetic insights, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company’s pipeline contains its most advanced candidates, PRAX-114 and PR

Aligos Therapeutics, a Phase 1 biotech developing oligonucleotide therapies for viral and liver diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company's lead focus is to develop a functional cure for Chronic Hepatitis B (CHB)

Eargo, which manufactures differentiated hearing aid systems, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Eargo believes its hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regul

Altitude Acquisition, a blank check company targeting the travel industry, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Atlanta, GA-based company plans to raise $300 million by offering 30 million units at $10. Each unit consists of

Altitude Acquisition, a blank check company targeting the travel industry, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Atlanta, GA-based company plans to raise $300 million by offering 30 million units at $10. Each unit consists of

10X Capital Venture Acquisition, a blank check company formed by 10X Capital targeting a tech-enabled business, filed on Friday with the SEC to raise up to $220 million in an initial public offering. The New York, NY-based company plans to raise $220 million by offering 22 millio

Tekkorp Digital Acquisition, a blank check company formed by Tekkorp Capital targeting the digital media and leisure industries, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Las Vegas, NV-based company plans to raise $300 million by

Spring Valley Acquisition, a blank check company formed by Pearl Energy Investment Management targeting the sustainability industry, filed on Friday with the SEC to raise up to $250 million in an initial public offering. The Dallas, TX-based company plans to raise $250 million by

Genesis Park Acquisition, a blank check company formed by Genesis Park targeting the aviation industry, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The Houston, TX-based company plans to raise $200 million by offering 20 million units a

Supernova Partners Acquisition, a blank check company formed by the co-founder of Zillow and other entrepreneur and investment veterans, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Washington, D.C.-based company plans to raise

Building upon the 14 public offerings last week, Nasdaq welcomed 15 IPOs this week, including the largest deal of the week, GoodRx (GDRX).

Motion Acquisition, a blank check company formed by the former CEO of Fleetmatics targeting the telematics industry, filed on Friday with the SEC to raise up to $130 million in an initial public offering. The New York, NY-based company plans to raise $130 million by offering 13 m

Yellowstone Acquisition, a blank check company formed by Boston Omaha Corp, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The Omaha, Nebraska-based company plans to raise $200 million by offering 20 million units at $10. Each unit co

5:01 Acquisition, a blank check company formed by 5AM Ventures, filed on Friday with the SEC to raise up to $80 million in an initial public offering. The San Francisco, CA-based company plans to raise $80 million by offering 8 million shares at $10. Unlike an ordi